Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

PROState Pathway Embedded Comparative Trial

NCT04400656 is registered in ClinicalTrials.gov with Imperial College London as lead sponsor.

NCT NCT04400656
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04400656 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
PROState Pathway Embedded Comparative Trial
Lead sponsor
Imperial College London
Phase
Observational
Overall status
Completed
Start date
September 8, 2020
Completion date
August 31, 2022
Enrollment
139 (actual)
Sites
3

Conditions

As the registry lists them; a condition with its own page is linked.

metastatic prostate cancer, metastatic prostate carcinoma in the soft tissue, non-metastatic prostate cancer, prostate adenocarcinoma, prostate cancer, prostate cancer metastatic